U.S. Customs and Border Protection (CBP) has issued a reminder to the pharmaceutical trade community regarding their legal obligations under the Trump Administration's Executive Order, "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients." This order involves price targets for prescription drugs aimed at reducing healthcare costs in the United States.
CBP emphasized that declaring incorrect values on import or export documentation is considered trade evasion. The agency stated it would pursue any violations thoroughly. Such violations can be reported through CBP's e-Allegations Online Trade Violation Reporting System.
For updates and guidance from the CBP Office of Trade, individuals are encouraged to follow them on X @CBPTradeGov and LinkedIn.
The CBP describes itself as America's frontline, being the nation's largest law enforcement organization and the world's first unified border management agency. With over 65,000 personnel, CBP is tasked with protecting America across various domains while facilitating lawful travel and trade. The agency also focuses on enhancing national security through innovation and collaboration.
